Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A
Issue: Mar/Apr 2011 - Volume 15, Number 2
View All Articles in Issue
Abstract: In the pediatric patient, histamine2-receptor antagonists and/or proton pump inhibitors are recommended for effective therapy of gastroesophageal reflux disease. Proton pump inhibitors, a group of drugs whose main action is a pronounced and long-lasting reduction of gastric acid production, are more cost effective than histamine2-receptor antagonists because of long-term and enhanced treatment outcome. The compounding of proton pump inhibitors is an exacting procedure. Compounding pharmacists have the potential to provide optimal pharmacologic treatment of gastroesophageal reflux disease to a young population that requires special attention.
Related Keywords: Lindsay Corsini, PharmD, LaVonn A. Williams, gastroesophageal reflux disease, GERD, children, infants, proton pump inhibitors, formulations, lansoprazole, omeprazole, pantoprazole, oral liquid suspensions
Related Categories: FORMULATIONS, GASTROENTEROLOGY, PEDIATRICS
Download in electronic PDF format for $35